# Expanded Access for Iberdomide

> **NCT07434960** · — · AVAILABLE · sponsor: **Bristol-Myers Squibb**

## Conditions studied

_None listed._

## Interventions

- **DRUG:** Iberdomide

## Key facts

- **NCT ID:** NCT07434960
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07434960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07434960, "Expanded Access for Iberdomide". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07434960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*